The present disclosure relates to a system for generating a predefined electrical signal in an MR scanner for use in electrical stimulation of a subject during MRI or functional MRI of said subject, wherein said MR scanner is located inside a shielded MRI room. The system comprises a control unit to be located outside the MRI room for generating an electrical signal and an electrical to optical converter to be located outside the MRI room for converting said electrical signal to a corresponding optical signal. An optical transmitting element, such as an optical fiber, is used for transmitting the optical signal into the MRI room, and an optical to electrical converter is used for converting the optical signal to said predefined electrical signal for electrical stimulation of the subject during magnetic resonance imaging. The optical to electrical converter is configured for being located inside the MRI room and for operation during magnetic resonance imaging.

An AIMD includes a conductive housing, an electrically conductive ferrule with an insulator hermetically sealing the ferrule opening. A conductive pathway is hermetically sealed and disposed through the insulator. A filter capacitor is disposed on a circuit board within the housing and has a dielectric body supporting at least two active and two ground electrode plates interleaved, wherein the at least two active electrode plates are electrically connected to the conductive pathway on the device side, and the at least two ground electrode plates are electrically coupled to either the ferrule and/or the conductive housing. The dielectric body has a dielectric constant less than 1000 and a capacitance of between 10 and 20,000 picofarads. The filter capacitor is configured for EMI filtering of MRI high RF pulsed power by a low ESR, wherein the ESR of the filter capacitor at an MRI RF pulsed frequency or range of frequencies is less than 2.0 ohms.

One or more antennas are electrically coupled to one or more switches of an implantable medical device (IMD) in which the one or more switches are additionally electrically coupled to one or more lead wires of an IMD lead. The one or more switches also are electrically coupled to one or more electrodes or electrical circuitry of the IMD's implantable pulse generator (IPG). In response to exposure of the IMD to an energetic electromagnetic field, a voltage signal is induced in the one or more antennas and provided, possibly via one more filters, as a control signal to the one or more switches. Receipt of the control signal by the one or more switches automatically configures the one or more switches into a non-conductive state, thereby electrically isolating the one or more lead wires from the one or more electrodes or the IPG electrical circuitry.

Embodiments herein relate to implantable cancer therapy electrodes with reduced magnetic resonance imaging artifacts. In an embodiment, a lead for a cancer treatment system can include a lead body with a proximal end and a distal end and defining a lumen, and one or more electric field generating electrodes, wherein the one or more electric field generating electrodes can be disposed along a length of the lead body. The one or more electric field generating electrodes include a ribbon wire with a thickness of the ribbon wire in a radial direction with respect to the lead body of less than 0.005 inches, or a walled tube with a thickness of the walled tube less than 0.005 inches, or a sputter coating with a thickness of the sputter coating in a radial direction with respect to a lead body of less than 0.005 inches. Other embodiments are also included herein.

A system for forming surface modified substrates includes a laser system, and a laser processing chamber. A laser scanner automatically controls a position of the laser beam or an x-y translating stage upon which the laser processing chamber is mounted thereon for scanning the laser beam relative to a substrate of material (M) having a bulk portion and an outer surface integrated with the bulk portion, and a coating including metal organic molecules including at least one metal X or particles of metal X on the outer surface. At laser-heated spots atoms of X from the metal coating diffuse into the outer surface to form a modified surface layer including both M and X. The modified surface layer has a thickness of 1 nm, and a 25° C. electrical conductivity ≥2.5% above or ≤2.5% below a 25° C. electrical conductivity in the bulk portion.

In some examples, a method including detecting, via processing circuitry, an induced voltage in at least one of an electrode or a lead conductor of an implantable medical device, wherein the induced voltage is induced in the at least one of the electrode or the lead conductor of the implantable medical device by a radio frequency (RF) field generated by a magnetic resonance imaging (MRI) scanner; and modifying, via the processing circuitry, an MRI scan based on the detected induced voltage.

A hermetically sealed feedthrough assembly for an active implantable medical device having an oxide-resistant electrical attachment for connection to an EMI filter, an EMI filter circuit board, an AIMD circuit board, or AIMD electronics. The oxide-resistant electrical attachment, including an oxide-resistant sputter layer 165 is disposed on the device side surface of the hermetic seal ferrule over which an ECA stripe is provided. The ECA stripe may comprise one of a thermal-setting electrically conductive adhesive, an electrically conductive polymer, an electrically conductive epoxy, an electrically conductive silicone, an electrically conductive polyimide, or a thermal-setting electrically conductive polyimide, such as those manufactured by Ablestick Corporation. The oxide-free electrical attachment between the ECA stripe and the filter or AIMD circuits may comprise one of gold, platinum, palladium, silver, iridium, rhenium, rhodium, tantalum, tungsten, niobium, zirconium, vanadium, and combinations or alloys thereof.

Implantable medical systems that include an implantable medical lead coupled to an implantable medical device for purposes of electrical stimulation therapy and/or sensing of physiological signals includes at least one twisted pair of conductors within the implantable medical lead. The twisted pair corresponds to a stimulation or sensing channel of the implantable medical device. The twisted pair provides attenuation of electromagnetic interference noise that is present at the lead or lead extension. The twisted pair may be present in a lumen of the implantable medical lead or encapsulated by the lead body. The twisted pair, along with any other conductors of the lead, may be of a linear configuration or may be coiled.

A shield layer is added to an existing lead or lead extension by applying the shield layer to the lead body between the proximal contact and distal electrode of the lead body. The shield layer may be covered with an outer insulative layer. An inner insulative layer may be applied over the lead body prior to adding the shield layer and the outer insulative layer. The shield layer may have a terminator applied to the end of the shield layer to prevent migration of the shield layer through the outer insulative layer. The shield layer may be of various forms including a tubular braided wire structure or a tubular foil. The tubular braided wire structure may be applied to the lead body by utilizing the lead body as a mandrel within a braiding machine.

A method of localizing brain regions for the purpose of guiding placement of electrodes and related implants is disclosed. The inventive method involves effecting a pulse in a patient's brain, temporally aligning readings taken from an electrode at various depths, measuring local field potentials at each depth during interstimulus intervals, performing a coherence analysis comparing the local field potential measurements of the different depths, and determining a corresponding brain region for the depths compared.